|
|
|
|
 |
BusinessWeek: July 29, 1996 |
|
|
ONLINE FEATURES
Book Reviews
BW Video
Columnists
Interactive Gallery
Newsletters
Past Covers
Philanthropy
Podcasts
Special Reports
BLOGS
Auto Beat
Bangalore Tigers
Blogspotting
Brand New Day
Byte of the Apple
Economics Unbound
Eye on Asia
Fine On Media
Green Biz
Hot Property
Investing Insights
Management IQ
NEXT: Innovation
NussbaumOnDesign
Tech Beat
Working Parents
TECHNOLOGY
J.D. Power Ratings
Product Reviews
Tech Stats
Wildstrom: Tech Maven
AUTOS
Home Page
Auto Reviews
Classic Cars
Car Care & Safety
Hybrids
INNOVATION
& DESIGN Home Page Architecture Brand Equity Auto Design Game Room SMALLBIZ Smart Answers Success Stories Today's Tip INVESTING Investing: Europe Annual Reports BW 50 S&P Picks & Pans Stock Screeners Free S&P Stock Report SCOREBOARDS Hot Growth 100 Mutual Funds Info Tech 100 S&P 500 B-SCHOOLS Undergrad Programs MBA Blogs MBA Profiles MBA Rankings Who's Hiring Grads |
|
Inside Wall Street
A LASER FACELIFT FOR EQUIMED
EquiMed owns or operates 30 radiation oncology therapy centers and 18 ophthalmology clinics in 16 states. These include seven ambulatory surgical units. Palomar makes lasers, used mainly for burns, cosmetic dermatology, and hair removal. Palomar's EpiLaser won a Food & Drug Administration O.K. in July for dermatological applications. By next year, EquiMed and Palomar expect to have set up 50 to 60 laser centers around the country. Each center, estimates one analyst, could bring in yearly revenues of $2 million, for a total of $100 million. EquiMed and Palomar will split sales and earnings equally. Analyst Craig Dickson of Everen Securities projects that, even before any contribution from laser centers, EquiMed will earn 45 cents this year and 85 cents next, vs. 31 cents in 1995. Now at 7, EquiMed is worth 20, figures Dickson. Return to top   Return to top | |
|
|
|
|
|
Copyright 1991-2008 by The McGraw-Hill Companies Inc. All rights reserved.Terms of Use | Privacy Notice |
